J
John S. Thompson
Researcher at University of Kentucky
Publications - 86
Citations - 2586
John S. Thompson is an academic researcher from University of Kentucky. The author has contributed to research in topics: Transplantation & Antigen. The author has an hindex of 27, co-authored 86 publications receiving 2535 citations. Previous affiliations of John S. Thompson include Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID mice
TL;DR: It is found that total body irradiation (TBI) was essential to induce acute graft-versus-host disease (GVHD) after allogeneic H-2-incompatible splenocyte (SP) transplantation in SCID mice and significantly increased both serum and colonic tumor necrosis factor-alpha (TNF-alpha, interleukin-1 alpha, and IL-6 when compared with non-TBI regimens and normal controls.
Journal ArticleDOI
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial
TL;DR: A multi-centre, randomised trial was undertaken to determine the effects of ex-vivo T-cell depletion versus methotrexate and cyclosporine immunosuppression on 3-year disease-free survival.
Journal ArticleDOI
Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins.
TL;DR: Concern is raised about the use of whole blood from multiparous donors particularly when multiple transfusions must be administered after over five years had elapsed since the last pregnancy.
Journal ArticleDOI
Effect of smoking on human natural killer cell activity.
TL;DR: Results suggest that smoking‐induced alterations in NK activity may have a role in the pathogenesis of smoking‐associated carcinoma of the lung.
Journal ArticleDOI
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
Gary Barone,Cheng Tao Chang,M. Gerry Choc,Jon B. Klein,Christopher L. Marsh,John A. Meligeni,David I. Min,Mark D. Pescovitz,Raymond Pollak,Timothy L. Pruett,James B. Stinson,John S. Thompson,Eva M. Vasquez,Thomas Waid,Duane G. Wombolt,R. Wong +15 more
TL;DR: The findings suggest that de novo use of cyclosporine emulsion may simplify and improve management of organ transplant recipients and that the PK advantages of cyclOSporineEmulsion may translate into clinical benefits.